Analysis of Coagulation and Fibrinolysis after Intravenous Anisoylated Plasminogen Streptokinase Activator Complex or Heparin in Patients with Acute Myocardial Infarction
- 1 January 1987
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 33 (3) , 253-260
- https://doi.org/10.2165/00003495-198700333-00047
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarctionThrombosis Research, 1985
- Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.Heart, 1985
- Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.Journal of Clinical Investigation, 1984
- Acylated Streptokinase – Plasminogen Complex in Patients with Acute Myocardial InfarctionThrombosis and Haemostasis, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- A Comparison of Acylated Streptokinase-Plasminogen Complex and Streptokinase in Healthy VolunteersThrombosis and Haemostasis, 1982
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Methods for Determination of Plasmin, Antiplasmin and Plasminogen by Means of Substrate S-2251Pathophysiology of Haemostasis and Thrombosis, 1978
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957